Responder Analysis Evaluating the Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) in Patients With Moderate to Severe Asthma With Versus Without Fixed Airflow Obstruction (FAO)

被引：0

|

作者：

Tashkin, D. P.

Chipps, B. E.

Uryniak, T.

Trudo, F.

机构：

来源：

ALLERGY AND ASTHMA PROCEEDINGS | 2014年 / 35卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：85 / 86

页数：2

相关论文

共 50 条

[21] Cardiac safety of budesonide (BUD)/Formoterol (FM) pressurized metered-dose inhaler (pMDI): Pooled data from clinical studies of children, adolescents, and adults with asthma
Peters, S. P.
Rosenwasser, L. J.
Vervaet, P.
O'Brien, C. D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S155 - S155
[22] Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial
Zangrilli, James
Mansfield, Lyndon E.
Uryniak, Tom
O'Brien, Christopher D.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (03) : 258 - 265
[23] Patient satisfaction with budesonide and formoterol in one pressurized metered-dose inhaler in patients with asthma
Baker, James
Martin, Paula
Parasuraman, Bhash
CHEST, 2007, 132 (04) : 509S - 510S
[24] Comparative bronchodilatory effects of formoterol dry powder inhaler (DPI) versus the combination of formoterol and budesonide pressurized metered-dose inhaler (pMDI)
Mezzanotte, W. S.
Miller, C. J.
Senn, S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S248 - S248
[25] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Symptoms of Chronic Obstructive Pulmonary Disease (COPD) in Patients with Moderate to Very Severe COPD
Tashkin, D. P.
Rennard, S. I.
Ramachandran, S.
Martin, P.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[26] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Pulmonary Function in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD).
Tashkin, D. P.
Rennard, S. I.
McElhattan, J.
Goldman, M.
Martin, U. J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[27] Effects of Doubling the Highest Indicated Dose of Budesonide/Formoterol (BUD/FM) on Lung Function and Symptoms in Moderate-to-Severe Asthma with Fixed Airflow Obstruction (FAO)
DePietro, Michael
Tashkin, Donald P.
Chipps, Bradley E.
Trudo, Frank
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB4 - AB4
[28] Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients
Peters, Stephen P.
Prenner, Bruce M.
Mezzanotte, William S.
Martin, Paula
O'Brien, Christopher D.
ALLERGY AND ASTHMA PROCEEDINGS, 2008, 29 (05) : 499 - 516
[29] Long-Term Safety Of Budesonide/formoterol Pressurized Metered-Dose Inhaler (PMDI) And Budesonide PMDI In African-American Patients With Asthma: Asthma Exacerbations And Adverse Events
Brown, R. W.
Uryniak, T.
Lampl, K. L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[30] Effect of Fluticasone/Formoterol Pressurized Metered-Dose Inhaler (pMDI) in Early Management of Acute Exacerbations of Asthma
Agarwal, S. K.
Sharma, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181

← 1 2 3 4 5 →